Oya Y - Search Results

1

Pneumonitis associated with pembrolizumab plus chemotherapy for non-squamous non-small cell lung cancer.

Fujimoto D, Miura S, Tomii K, Sumikawa H, Yoshimura K, Wakuda K, Oya Y, Yokoyama T, Kijima T, Asao T, Tamiya M, Nakamura A, Yoshioka H, Tokito T, Murakami S, Tamiya A, Yokouchi H, Watanabe S, Yamaguchi O, Morinaga R, Jodai T, Ito K, Shiraishi Y, Kogure Y, Shibaki R, Yamamoto N. Fujimoto D, et al. Among authors: oya y. Sci Rep. 2023 Mar 6;13(1):3698. doi: 10.1038/s41598-023-30676-y. Sci Rep. 2023. PMID: 36878936 Free PMC article.

2

Clinical impact of crizotinib on central nervous system progression in ALK-positive non-small lung cancer.

Yoshida T, Oya Y, Tanaka K, Shimizu J, Horio Y, Kuroda H, Sakao Y, Hida T, Yatabe Y. Yoshida T, et al. Among authors: oya y. Lung Cancer. 2016 Jul;97:43-7. doi: 10.1016/j.lungcan.2016.04.006. Epub 2016 Apr 23. Lung Cancer. 2016. PMID: 27237026

3

Differential Crizotinib Response Duration Among ALK Fusion Variants in ALK-Positive Non-Small-Cell Lung Cancer.

Yoshida T, Oya Y, Tanaka K, Shimizu J, Horio Y, Kuroda H, Sakao Y, Hida T, Yatabe Y. Yoshida T, et al. Among authors: oya y. J Clin Oncol. 2016 Oct 1;34(28):3383-9. doi: 10.1200/JCO.2015.65.8732. Epub 2016 Jun 27. J Clin Oncol. 2016. PMID: 27354483

4

Unique prevalence of oncogenic genetic alterations in young patients with lung adenocarcinoma.

Tanaka K, Hida T, Oya Y, Yoshida T, Shimizu J, Mizuno T, Kuroda H, Sakakura N, Yoshimura K, Horio Y, Sakao Y, Yatabe Y. Tanaka K, et al. Among authors: oya y. Cancer. 2017 May 15;123(10):1731-1740. doi: 10.1002/cncr.30539. Epub 2017 Feb 8. Cancer. 2017. PMID: 28177518 Free article.

5

Clinical outcomes of platinum-based chemotherapy according to T790M mutation status in EGFR-positive non-small cell lung cancer patients after initial EGFR-TKI failure.

Yoshida T, Kuroda H, Oya Y, Shimizu J, Horio Y, Sakao Y, Hida T, Yatabe Y. Yoshida T, et al. Among authors: oya y. Lung Cancer. 2017 Jul;109:89-91. doi: 10.1016/j.lungcan.2017.05.001. Epub 2017 May 3. Lung Cancer. 2017. PMID: 28577956

6

Clinical Efficacy of Alectinib in Patients with ALK-Rearranged Non-small Cell Lung Cancer After Ceritinib Failure.

Oya Y, Yoshida T, Kuroda H, Shimizu J, Horio Y, Sakao Y, Hida T, Yatabe Y. Oya Y, et al. Anticancer Res. 2017 Nov;37(11):6477-6480. doi: 10.21873/anticanres.12103. Anticancer Res. 2017. PMID: 29061835

7

Efficacy of Immune Checkpoint Inhibitor Monotherapy for Advanced Non-Small-Cell Lung Cancer with ALK Rearrangement.

Oya Y, Kuroda H, Nakada T, Takahashi Y, Sakakura N, Hida T. Oya Y, et al. Int J Mol Sci. 2020 Apr 9;21(7):2623. doi: 10.3390/ijms21072623. Int J Mol Sci. 2020. PMID: 32283823 Free PMC article.

8

Propensity score analysis of overall survival between first- and second-generation EGFR-TKIs using real-world data.

Ito K, Murotani K, Kubo A, Kunii E, Taniguchi H, Shindoh J, Asada K, Imaizumi K, Takahashi K, Karayama M, Okuno M, Inui N, Hataji O, Morikawa S, Hayai S, Suda T, Abe T, Tsuda T, Yamagichi T, Kimura T, Oya Y, Yoshida T, Hida T. Ito K, et al. Among authors: oya y. Cancer Sci. 2020 Oct;111(10):3705-3713. doi: 10.1111/cas.14560. Epub 2020 Aug 5. Cancer Sci. 2020. PMID: 32639668 Free PMC article.

9

Clinical utility of liquid biopsy for EGFR driver, T790M mutation and EGFR amplification in plasma in patients with acquired resistance to afatinib.

Oya Y, Yoshida T, Asada K, Oguri T, Inui N, Morikawa S, Ito K, Kimura T, Kunii E, Matsui T, Kubo A, Kato T, Abe T, Tsuda T, Hida T. Oya Y, et al. BMC Cancer. 2021 Jan 12;21(1):57. doi: 10.1186/s12885-020-07777-2. BMC Cancer. 2021. PMID: 33435905 Free PMC article.

10

Sequential therapy of crizotinib followed by alectinib for non-small cell lung cancer harbouring anaplastic lymphoma kinase rearrangement (WJOG9516L): A multicenter retrospective cohort study.

Ito K, Yamanaka T, Hayashi H, Hattori Y, Nishino K, Kobayashi H, Oya Y, Yokoyama T, Seto T, Azuma K, Fukui T, Kozuki T, Nakamura A, Tanaka K, Hirano K, Yokoi T, Daga H, Sakata S, Fujimoto D, Mori M, Maeno K, Aoki T, Tamura A, Miura S, Watanabe S, Akamatsu H, Hataji O, Suzuki K, Hontsu S, Azuma K, Bessho A, Kubo A, Okuno M, Nakagawa K, Yamamoto N. Ito K, et al. Among authors: oya y. Eur J Cancer. 2021 Mar;145:183-193. doi: 10.1016/j.ejca.2020.12.026. Epub 2021 Jan 22. Eur J Cancer. 2021. PMID: 33486442

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

280 results

Search Page